261 related articles for article (PubMed ID: 35763196)
1. Pre-clinical 2D and 3D toxicity response to a panel of nanomaterials; comparative assessment of NBM-induced liver toxicity.
Tutty MA; Vella G; Prina-Mello A
Drug Deliv Transl Res; 2022 Sep; 12(9):2157-2177. PubMed ID: 35763196
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials.
Tutty MA; Movia D; Prina-Mello A
Drug Deliv Transl Res; 2022 Sep; 12(9):2048-2074. PubMed ID: 35507131
[TBL] [Abstract][Full Text] [Related]
3. Evaluating nanobiomaterial-induced DNA strand breaks using the alkaline comet assay.
Tutty MA; Vella G; Vennemann A; Wiemann M; Prina-Mello A
Drug Deliv Transl Res; 2022 Sep; 12(9):2243-2258. PubMed ID: 35612707
[TBL] [Abstract][Full Text] [Related]
4. Two-Photon Microscopy Analysis of Gold Nanoparticle Uptake in 3D Cell Spheroids.
Rane TD; Armani AM
PLoS One; 2016; 11(12):e0167548. PubMed ID: 27936027
[TBL] [Abstract][Full Text] [Related]
5. A 3D spheroid model of quadruple cell co-culture with improved liver functions for hepatotoxicity prediction.
Sun B; Liang Z; Wang Y; Yu Y; Zhou X; Geng X; Li B
Toxicology; 2024 Jun; 505():153829. PubMed ID: 38740170
[TBL] [Abstract][Full Text] [Related]
6. A sub-chronic Xysmalobium undulatum hepatotoxicity investigation in HepG2/C3A spheroid cultures compared to an in vivo model.
Calitz C; Hamman JH; Fey SJ; Viljoen AM; Gouws C; Wrzesinski K
J Ethnopharmacol; 2019 Jul; 239():111897. PubMed ID: 31009705
[TBL] [Abstract][Full Text] [Related]
7. Fingerprinting Metabolic Activity and Tissue Integrity of 3D Lung Cancer Spheroids under Gold Nanowire Treatment.
Hashemzadeh H; Kelkawi AHA; Allahverdi A; Rothbauer M; Ertl P; Naderi-Manesh H
Cells; 2022 Jan; 11(3):. PubMed ID: 35159286
[TBL] [Abstract][Full Text] [Related]
8. A 3D cell printing-fabricated HepG2 liver spheroid model for high-content in situ quantification of drug-induced liver toxicity.
Hong S; Song JM
Biomater Sci; 2021 Sep; 9(17):5939-5950. PubMed ID: 34318795
[TBL] [Abstract][Full Text] [Related]
9. In vitro toxicity testing of nanoparticles in 3D cell culture.
Lee J; Lilly GD; Doty RC; Podsiadlo P; Kotov NA
Small; 2009 May; 5(10):1213-21. PubMed ID: 19263430
[TBL] [Abstract][Full Text] [Related]
10. Short and long-term effects of nanobiomaterials in fish cell lines. Applicability of RTgill-W1.
Hernández-Moreno D; Navas JM; Fernández-Cruz ML
Chemosphere; 2022 Dec; 309(Pt 1):136636. PubMed ID: 36181847
[TBL] [Abstract][Full Text] [Related]
11. Three dimensional spheroid cell culture for nanoparticle safety testing.
Sambale F; Lavrentieva A; Stahl F; Blume C; Stiesch M; Kasper C; Bahnemann D; Scheper T
J Biotechnol; 2015 Jul; 205():120-9. PubMed ID: 25595712
[TBL] [Abstract][Full Text] [Related]
12. Changes of physico-chemical properties of nano-biomaterials by digestion fluids affect the physiological properties of epithelial intestinal cells and barrier models.
Antonello G; Marucco A; Gazzano E; Kainourgios P; Ravagli C; Gonzalez-Paredes A; Sprio S; Padín-González E; Soliman MG; Beal D; Barbero F; Gasco P; Baldi G; Carriere M; Monopoli MP; Charitidis CA; Bergamaschi E; Fenoglio I; Riganti C
Part Fibre Toxicol; 2022 Jul; 19(1):49. PubMed ID: 35854319
[TBL] [Abstract][Full Text] [Related]
13. Biomimicry 3D gastrointestinal spheroid platform for the assessment of toxicity and inflammatory effects of zinc oxide nanoparticles.
Chia SL; Tay CY; Setyawati MI; Leong DT
Small; 2015 Feb; 11(6):702-12. PubMed ID: 25331163
[TBL] [Abstract][Full Text] [Related]
14. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Jan; 825():51-58. PubMed ID: 29307375
[TBL] [Abstract][Full Text] [Related]
15. Reprint of: A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Oct; 834():35-41. PubMed ID: 30173862
[TBL] [Abstract][Full Text] [Related]
16. Monolayer (2D) or spheroids (3D) cell cultures for nanotoxicological studies? Comparison of cytotoxicity and cell internalization of nanoparticles.
Juarez-Moreno K; Chávez-García D; Hirata G; Vazquez-Duhalt R
Toxicol In Vitro; 2022 Dec; 85():105461. PubMed ID: 36049398
[TBL] [Abstract][Full Text] [Related]
17. Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model.
Elje E; Mariussen E; Moriones OH; Bastús NG; Puntes V; Kohl Y; Dusinska M; Rundén-Pran E
Nanomaterials (Basel); 2020 Mar; 10(3):. PubMed ID: 32197356
[TBL] [Abstract][Full Text] [Related]
18. Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids.
Ma LD; Wang YT; Wang JR; Wu JL; Meng XS; Hu P; Mu X; Liang QL; Luo GA
Lab Chip; 2018 Aug; 18(17):2547-2562. PubMed ID: 30019731
[TBL] [Abstract][Full Text] [Related]
19. Suitability of 3D human brain spheroid models to distinguish toxic effects of gold and poly-lactic acid nanoparticles to assess biocompatibility for brain drug delivery.
Leite PEC; Pereira MR; Harris G; Pamies D; Dos Santos LMG; Granjeiro JM; Hogberg HT; Hartung T; Smirnova L
Part Fibre Toxicol; 2019 Jun; 16(1):22. PubMed ID: 31159811
[TBL] [Abstract][Full Text] [Related]
20. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
Conway GE; Shah UK; Llewellyn S; Cervena T; Evans SJ; Al Ali AS; Jenkins GJ; Clift MJD; Doak SH
Mutagenesis; 2020 Sep; 35(4):319-330. PubMed ID: 32780103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
